Federal contractor · CHAPEL HILL, NC

GLYCAN THERAPEUTICS CORPORATION

No contract obligations recorded for GLYCAN THERAPEUTICS CORPORATION in FY2026. Since FY2017: $693.7K.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
KYG3DZSMH4R7
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 693.7KFY2017
  2. 0FY2018

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for GLYCAN THERAPEUTICS CORPORATION in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

GLYCAN THERAPEUTICS CORPORATION received -$1.00 in federal assistance in FY2026, on 5 actions (0 new awards), −100% vs FY2025. Its largest program was 93.121 · Oral Diseases and Disorders Research (-$1.00).

Assistance · FY2026
-$1.00
New awards
0
Actions
5
Since FY2021
$15.3M

Assistance by fiscal year

  1. 3MFY2021
  2. 1.3MFY2022
  3. 3.6MFY2023
  4. 4.3MFY2024
  5. 3.2MFY2025
  6. -1FY2026

By type

  1. Grants-$1.000.0%

Top programs

  1. 93.121 · Oral Diseases and Disorders Research-$1.000.0%

Largest awards

  1. DEVELOPMENT OF A NEW CARBOHYDRATE-BASED ANTICOAGULANT DRUG$4.2M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Oct 26, 2020 – Jun 8, 2026· R44HL139187
  2. DEVELOPMENT OF ANTICOAGULANT SULFATED GLYCANS - SULFATED GLYCAN 8-MER IS A CARBOHYDRATE-BASED COMPOUND WITH ANTICOAGULANT ACTIVITY. THE…$2.5M
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Aug 15, 2023 – Jul 21, 2026· R44GM148100
  3. SYNTHESIS OF THE LIBRARY OF HEPARAN SULFATE HEXASACCHARIDE MIMETICS - PROJECT SUMMARY: HEPARAN SULFATE (HS) PLAY ROLES IN MANY IMPORTANT…$2.4M
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Sep 20, 2023 – Jun 17, 2026· R44GM145004
  4. DEVELOPMENT OF ANALYTICAL METHODS FOR GLYCOSAMINOGLYCANS FROM BIOLOGICAL SOURCES - THIS SBIR PHASE II PROPOSAL IS AIMED TO DEVELOP A…$2M
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Sep 16, 2022 – Apr 24, 2026· R44GM142304
  5. SULFATED CARBOHYDRATES FOR THE TREATMENT OF PERIODONTITIS - ABSTRACT PERIODONTITIS AFFECTS OVER HALF OF THE AMERICAN POPULATION AND HAS NO…$347.5K
    93.121 · Oral Diseases and Disorders Research· National Institutes of Health· Project grant· Sep 1, 2023 – Feb 19, 2026· R41DE032276

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.